PLRX vs TXT · $77.3M cap vs P/E 19, rev $7.52B
Pliant Therapeutics Inc (PLRX) versus Textron Inc (TXT) — a side-by-side from cached financials, not a winner call.
Pliant Therapeutics Inc (PLRX) is a biotechnology company listed on US.
Textron Inc (TXT) is a aerospace & defense company listed on US.
Latest reported PLRX revenue for 2025-12-31 was $0. Net income was -$149.3M. PLRX currently screens at market cap $77.3M.
Latest reported TXT revenue for 2026-07-04 was $7.52B. Net income was $468.0M. TXT currently screens at market cap $14.85B and trailing P/E 18.5.
PLRX currently screens at market cap $77.3M. TXT currently screens at market cap $14.85B and trailing P/E 18.5.
Not investment advice. Open the PLRX and TXT stock pages for the full models.
Not investment advice.